Clincosm LogoSign in Get a demo

Microarray Analysis of Gene Expression in Prostate Tissues

Sponsor
Stanford University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT00186368
Collaborator
National Institutes of Health (NIH) (NIH), University of Wisconsin, Madison (Other)
2,000
Enrollment
1
Location
379.9
Anticipated Duration (Months)
5.3
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of this study is to investigate gene expression profiles and biologic features of prostate tissue and how they relate to prostate cancer development and growth.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    2000 participants
    Observational Model:
    Other
    Time Perspective:
    Prospective
    Official Title:
    Microarray Analysis of Gene Expression in Prostate Tissues (Translating Prostate Cancer Gene Expression Sub-types)
    Actual Study Start Date :
    Apr 6, 1999
    Anticipated Primary Completion Date :
    Dec 1, 2030
    Anticipated Study Completion Date :
    Dec 1, 2030

    Outcome Measures

    Primary Outcome Measures

    1. Correlate genotype with pathologic phenotype and clinical outcome. [one time]

      The Tissue Bank will store all "Tissue Bank" consents. The patients will be given a unique identifier by the tissue bank. However, patients will need to be identified to link to clinical data and possible followup (if they have consented) via chart or tumor registries.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Male
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patient scheduled to undergo either a biopsy or surgery for a prostate condition.
    Exclusion Criteria:
    • Patients without a prostate condition

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Stanford University Cancer Center Stanford California United States 94305

    Sponsors and Collaborators

    • Stanford University
    • National Institutes of Health (NIH)
    • University of Wisconsin, Madison

    Investigators

    • Principal Investigator: James Brooks, MD, Stanford University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Stanford University
    ClinicalTrials.gov Identifier:
    NCT00186368
    Other Study ID Numbers:
    • PROS0009
    • PROS0009
    • 13873
    First Posted:
    Sep 16, 2005
    Last Update Posted:
    Jun 14, 2022
    Last Verified:
    Jun 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Stanford University
    Prostate cancer
    Gene expression
    tumor markers
    microarray analysis
    Additional relevant MeSH terms:
    Prostatic Neoplasms

    Study Results

    No Results Posted as of Jun 14, 2022